Sionna Therapeutics is trading at $6.79, up 5.13%, although no clear company-specific catalyst has been identified for September 2, 2026.
- Its official news page lists August 6, 2026, as the latest release.
- Shares gained 7.13% to $6.46 on September 1, 2026.
- Broader markets were mixed at 9:36 a.m. and did not provide a strong directional explanation; the immediate driver remains unclear.